Veterans who participate in research help validate breakthrough therapies like psychedelic-assisted treatment, making them safer, more accessible, and ultimately available through systems like the VA.



“The science is catching up to what many of us already know: these treatments work. Be part of proving it.”



Explore active and upcoming studies from our trusted research partners:
Atlanta, Georgia- MDMA Plus Exposure Therapy for PTSD – Link to Register
Location: Atlanta, Georgia
Description: The researchers will investigate MDMA in combination with Prolonged Exposure therapy (PE). Participants will take part in a 10-day therapy program and receive one guided MDMA session during that time. The goal is to see if this approach can make healing from trauma more effective for those who haven’t found full relief from standard treatments.
Become a participantNew York City, New York- Dose Optimization of MDMA-Assisted Therapy for PTSD (DosOp) – Link to Study
Location: New York City, New York
Description: This open-label study will determine the optimal number of treatment cycles of MDMA-AT (one cycle consists of one Experimental Session followed by three Integrative Sessions) for significant improvement in a sample of U.S. veterans with PTSD.
Become a participantNew Haven, Connecticut- Psilocybin for Symptom-Related Impairment – Link to Register for the Study
Location: New Haven, Connecticut
Description: The primary objective of this study is to investigate the safety, feasibility, and tolerability of psilocybin treatment in individuals with functional impairment due to psychiatric symptoms. The secondary objective of this study is to determine whether individuals with functional impairments due to psychiatric symptoms will experience statistically significant symptom reduction and functional improvement from baseline symptom measurements (Visit 3) to 1-week (Visit 7), 4-weeks (Visit 8), and 6-weeks (Visit 9) post dosing. The investigators will recruit individuals with mood, anxiety, trauma, addictive, or related symptomatology, and who have functional impairment associated with these symptoms. A DSM-5 diagnosis is not required (nor is it an exclusion).
Become a participantColumbus, Ohio- Psilocybin: A Study for Veterans with Post-Traumatic Stress Disorder (PTSD) – Link to Study
Location: Columbus, Ohio
Description: The study will demonstrate the safety and efficacy of psilocybin in treating post-traumatic stress disorder (PTSD) in veterans. Psilocybin-assisted therapy has shown great promise in treating anxiety symptoms that comprise post-traumatic stress disorder (PTSD). Current therapeutic treatments for PTSD are difficult to tolerate and limited in efficacy, especially in the US military veteran population. This study will examine the safety and efficacy of two psilocybin sessions, combined with psychotherapy, among military veterans with severe, treatment-resistant PTSD.
Become a participantHouston, Texas- State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma (STARLIGHT) – Link to Study
Location: Houston, Texas
Description: The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.
Become a participantSeattle, Washington- Psilocybin clinical trial for Alcohol Use Disorder & PTSD: PsiloStudy – Link to Study
Location: Seattle, Washington
Description: This first-of-its-kind study will explore the safety and effectiveness of psilocybin to treat alcohol use disorder (AUD) and for post-traumatic stress disorder (PTSD). Leading the study is Dr. Nathan Sackett, an addiction psychiatrist with the University of Washington’s Department of Psychiatry and Behavioral Sciences.
Become a participantBranford, CT- Breathwork Intervention for Veterans with Post-Traumatic Stress (PTS) – Link to Study
Location: Branford, CT
Description: Heroic Hearts Project, in partnership with Frequency Breathwork and Florida State University, is studying how cyclical breathwork can help veterans manage post-traumatic stress and improve overall well-being. The pilot program includes a guided in-person breathwork session, optional contrast therapy, and virtual follow-ups. Led by experts in trauma and mind-body medicine, the study aims to bring scientific evidence to the healing potential of breathwork for veterans.
Become a participant
Whether you’re a Veteran, clinician, policymaker, or ally—there’s a role for you here.

Connect with fellow advocates and drive change.

Fuel the mission. Fund access, advocacy, and hope.

Volunteer, attend events, or share your story.

Veteran die by suicide and drug
overdoses every day.

Veteran are 1.5x more likely to die
by overdose than civilians.

Over 200,000 Veteran have died from suicide and overdose
since 9/11.

leave the country they served for overseas psychedelic therapy because the system won’t support them.
“This isn’t just a crisis. It’s a moral failing. And we’re done waiting.”
VMHLC is powered by a national coalition of Veteran-led organizations, clinicians, researchers, advocates, and families—united in one mission: to end the suicide crisis and revolutionize mental health care.
“We are Veterans still in service—fighting for the right to heal.”